Additional File 5 of Abnormal Signal Pathways and Tumor Heterogeneity in Osteosarcoma

Yang Sun,Chunming Zhang,Qiongxuan Fang,Wenqiang Zhang,Wei Liu

DOI: https://doi.org/10.6084/m9.figshare.22598630

2023-01-01

Abstract:Additional file 5: Table S4. Significantly different genes of the hMSC_BMP2+IBMX group.

What problem does this paper attempt to address?

Supplementary Table 1 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Humam Kadara,Li Shen,Junya Fujimoto,Pierre Saintigny,Chi-Wan Chow,Wenhua Lang,Zuoming Chu,Melinda Garcia,Mohamed Kabbout,You-Hong Fan,Carmen Behrens,Diane A. Liu,Li Mao,J. Jack Lee,Kathryn A. Gold,Jing Wang,Kevin R. Coombes,Edward S. Kim,Waun Ki Hong,Ignacio I. Wistuba

DOI: https://doi.org/10.1158/1940-6207.22524609.v1

2023-01-01

Abstract:XLSX file - 68K, Supplementary table depicting 1165 genes significantly differentially expressed by site in the molecular field of injury
Additional File 3 of Bioinformatics Integrated Analysis to Investigate Candidate Biomarkers and Associated Metabolites in Osteosarcoma

Jun Wang,Mingzhi Gong,Zhenggang Xiong,Yangyang Zhao,Deguo Xing

DOI: https://doi.org/10.6084/m9.figshare.14913465

2021-01-01

Abstract:Additional file 3: Table S1. Survival data and results for survival analysis of all feature genes.
Table S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419828

2023-01-01

Abstract:Supplementary Table S2. Patient characteristics
Table S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419825.v1

2023-01-01

Abstract:Supplementary Table S3. Demographics of the included 332 osteosarcomas.
Additional File 7 of Transcriptomics and Metabolomics Reveal Changes in the Regulatory Mechanisms of Osteosarcoma under Different Culture Methods in Vitro

Sen Yang,Zhi Tian,Yi Feng,Kun Zhang,Yongchun Pan,Yuan Li,Zhichao Wang,Wenhao Wei,Xiaochen Qiao,Ruhao Zhou,Lei Yan,Qian Li,Guo Hua,Jie Yuan,Pengcui Li,Zhi Li

DOI: https://doi.org/10.6084/m9.figshare.22614992

2023-01-01

Abstract:Additional file 7: Table S3. Pathway information from combined transcriptome with metabolomics analysis.
Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419831

2023-01-01

Abstract:Supplementary Table S1. Primers for qRT-PCR and MSP
Additional File 8 of the Immune Subtypes and Landscape of Sarcomas

Wei‐Hung Weng,Yuling Lin,Zhang Li,Cong Tan,Jiaoyan Lv,I Weng Lao,Wenhuo Hu,Zhenzhong Deng,Zebing Liu,Jian Wang,Ming Xu

DOI: https://doi.org/10.6084/m9.figshare.21202086

2022-01-01

Abstract:Additional file8. Table S5: List of six prognostic genes in the blue module.
Figure S5 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419837.v1

2023-01-01

Abstract:Supplementary figure S5. DAC treatment did not increase the risk of osteosarcoma proliferation.
Additional File 2: Figure S1. of Aberrant KDM5B Expression Promotes Aggressive Breast Cancer Through MALAT1 Overexpression and Downregulation of Hsa-Mir-448

Oluwaseun Adebayo Bamodu,Wen‐Chien Huang,Wei‐Hwa Lee,Alexander T.H. Wu,Liang Wang,Michael S. Hsiao,Chi‐Tai Yeh,Tsu‐Yi Chao

DOI: https://doi.org/10.6084/m9.figshare.c.3621719_d1.v1

2016-01-01

Abstract:Relative expression of KDM5B, MALAT1, SNAIL, Vimentin and miR 448 normalized against GAPDH in MCF10A WT, MCF10A OE, MDA-MB-231 WT and MDA-MB-231 KD cells. Data are representative of 3 independent experiments and analyzed by student’s t-test. All data are shown as mean ± SEM. WT, wild type; OE, KDM5B overexpressed; KD, knockdown using shKDM5B clone II. (DOCX 519 kb)
Figure S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419843.v1

2023-01-01

Abstract:Supplementary figure S3. Flow cytometry analyses of tumor draining lymph nodes.
Additional File 2 of A Tumor Microenvironment-Based Prognostic Index for Osteosarcoma

Changwu Wu,Siming Gong,Yingjuan Duan,Chao Deng,Sonja Kallendrusch,Laura Berninghausen,Georg Osterhoff,Nikolas Schopow

DOI: https://doi.org/10.6084/m9.figshare.22631607

2023-01-01

Abstract:Additional file 2: Table S2. DEGs between high- and low-ImmuneScore groups. Table S3. DEGs between high- and low-StromalScore groups. Table S4. Genes of green, blue and yellow modules in WGCNA. Table S6. DEGs between high- and low-TMEindex groups. Table S7. Correlations between TMEindex and IC50 value in different drugs. Table S8. Target pathway of 29 TMEindex-related drugs.
Supplementary Table S16 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Dongliang Leng,Ziyi Yang,Heng Sun,Chengcheng Song,Chen Huang,Ka U. Ip,Guokai Chen,Chu-Xia Deng,Xiaohua Douglas Zhang,Qi Zhao

DOI: https://doi.org/10.1158/1078-0432.24229812.v1

2023-01-01

Abstract:Supplementary Table S16. Cell types determination based on different annotation references.
Additional File 19 of Single-cell RNA-seq Reveals the Genesis and Heterogeneity of Tumor Microenvironment in Pancreatic Undifferentiated Carcinoma with Osteoclast-Like Giant-Cells

Xinbo Wang,Jiaying Miao,Sizhen Wang,Rongxi Shen,Shuo Zhang,Yurao Tian,Min Li,Daxing Zhu,Anlong Yao,Wei Bao,Qun Zhang,Xingming Tang,Xinyun Wang,Jieshou Li

DOI: https://doi.org/10.6084/m9.figshare.20130935

2022-01-01

Abstract:Additional file 19: Table S11. beam_markers.
Exploring the heterogeneity of osteosarcoma cell characteristics and metabolic states and their association with clinical prognosis

Sen Qin,YaoFeng Hu,RuCui Deng,Zhe Wang

DOI: https://doi.org/10.3389/fimmu.2024.1507476

IF: 7.3

2024-12-07

Frontiers in Immunology

Abstract:Background: Osteosarcoma is a malignant tumor originating from mesenchymal bone tissue, characterized by high malignancy and poor prognosis. Despite progress in comprehensive treatment approaches, the five-year survival rate remains largely unchanged, highlighting the need to clarify its underlying mechanisms and discover new therapeutic targets. Methods: This study utilized RNA sequencing data from multiple public databases, encompassing osteosarcoma samples and healthy controls, along with single-cell RNA sequencing data. Various methods were utilized, such as differential expression analysis of genes, analysis of metabolic pathways, and weighted gene co-expression network analysis (WGCNA), to pinpoint crucial genes. Using this list of genes, we developed and validated a prognostic model that incorporated risk signatures, and we evaluated the effectiveness of the model through survival analysis, immune cell infiltration examination, and drug sensitivity evaluation. Results: We analyzed gene expression and metabolic pathways in nine samples using single-cell sequencing data. Initially, we performed quality control and clustering, identifying 21 statistically significant cell subpopulations. Metabolic analyses of these subpopulations revealed heterogeneous activation of metabolic pathways. Focusing on the osteoblastic cell subpopulation, we further subdivided it into six groups and examined their gene expression and differentiation capabilities. Differential expression and enrichment analyses indicated that tumor tissues were enriched in cytoskeletal and structural pathways. Through WGCNA, we identified core genes negatively correlated with four highly activated metabolic pathways. Using osteosarcoma patient data, we developed a risk signature model that demonstrated robust prognostic predictions across three independent cohorts. Ultimately, we performed a thorough examination of the model, which encompassed clinical and pathological characteristics, enrichment analysis, pathways associated with cancer markers, and scores of immune infiltration, highlighting notable and complex disparities between high-risk and low-risk populations. Conclusion: This research clarifies the molecular mechanisms and metabolic features associated with osteosarcoma and how they relate to patient outcomes, offering novel perspectives and approaches for targeted therapy and prognostic assessment in osteosarcoma.

immunology
Supplementary Data from Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases

Di Wang,Xiaohui Niu,Zhijie Wang,Cheng-Li Song,Zhen Huang,Ke-Neng Chen,Jianchun Duan,Hua Bai,Jiachen Xu,Jun Zhao,Yu Wang,Minglei Zhuo,X. Sunney Xie,Xiaozheng Kang,Yanhua Tian,Liangliang Cai,Jie-Fei Han,Tongtong An,Yu Sun,Shugeng Gao,Jianming Ying,Luhua Wang,Jie He,Jie Wang

DOI: https://doi.org/10.1158/0008-5472.22421436

2023-01-01

Abstract:Supplementary Table S1's detail information of mutations in each patient
Additional File 14 of A Single-Cell Survey of Cellular Hierarchy in Acute Myeloid Leukemia

Jinliang Wu,Yanyu Xiao,Jie Sun,Huiyu Sun,Haide Chen,Yuanyuan Zhu,Haidong Fu,Chengxuan Yu,E Weigao,Shih‐Wei Lai,Lifeng Ma,Jiaqi Li,Lijiang Fei,Mengmeng Jiang,Jingjing Wang,Fang Ye,Renying Wang,Ziyu Zhou,Guodong Zhang,Tingyue Zhang,Qiong Ding,Zou Wang,Sheng Hao,Lizhen Liu,Weiyan Zheng,Jingsong He,Weijia Huang,Yungui Wang,Jin Xie,Tiefeng Li,Tao Cheng,Xiaoping Han,He Huang,Guoji Guo

DOI: https://doi.org/10.6084/m9.figshare.13011042

2020-01-01

Abstract:Additional file 14: Table S1. Marker genes of individual t-SNE map
Abstract 1418: Screening and Identification of Key Surface Markers of Mesenchymal Stem Cell Osteogenic Differentiation and Osteosarcoma Development

Tingting Ren,Sajida Piperdi,Amy Y. Park,Richard Gorlick

DOI: https://doi.org/10.1158/1538-7445.am2015-1418

IF: 11.2

2015-01-01

Cancer Research

Abstract:Abstract Introduction: Osteosarcoma (OS) is the most common primary malignant tumor of bone in children and young adults. Knowledge about its cell of origin is limited, making new treatments difficult to develop. Our aim is to screen and identify the key surface markers of mesenchymal stem cell (MSC) to osteogenic differentiation and OS malignant transformation. Methods: A list of differentially expressed genes with a statistically significant p-value <0.05 was obtained by microarray analysis from MSCs and osteoblasts (OB). MSCs were differentiated into osteoblasts, adipocytes and chondrocytes and confirmed by alizarin red staining, oil red O staining and collagen II immunohistchemistry, respectively. Western blots were then performed to identify the expression of selected surface markers during the MSC differentiation and compared to those of OS cells. Results: Nine genes were obtained with a p-value <0.02, which are differentially expressed between MSC and OB. Four of them were correlated with cell adhesion and metastasis. The expression profile of CD49b was distinct, where it was down regulated only during MSC osteogenic differentiation and over expressed in OS cell lines. Conclusions: Cell adhesion may have an important role during MSC differentiation. CD49b is a unique marker during MSC osteogenic differentiation and may play a significant role in osteoasarcoma malignant transformation. In the future we plan to determine the function and mechanism of CD49b during MSCs osteogenic differentiation and osteosarcoma malignant transformation in vitro. We will define the clinical significance of CD49b in osteosarcoma through immunohistochemistry of patient samples and functional analyses. Citation Format: Tingting Ren, Sajida Piperdi, Amy Y. Park, Richard Gorlick. Screening and identification of key surface markers of mesenchymal stem cell osteogenic differentiation and osteosarcoma development. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 1418. doi:10.1158/1538-7445.AM2015-1418
Comprehensive investigation of tumor immune microenvironment and prognostic biomarkers in osteosarcoma through integrated bulk and single-cell transcriptomic analysis

Shaoyan Shi,Li Zhang,Xiaohua Guo

DOI: https://doi.org/10.3389/fimmu.2024.1424950

2024-07-23

Abstract:Osteosarcoma (OS) is an aggressive and highly lethal bone tumor, highlighting the urgent need for further exploration of its underlying mechanisms. In this study, we conducted analyses utilizing bulk transcriptome sequencing data of OS and healthy control samples, as well as single cell sequencing data, obtained from public databases. Initially, we evaluated the differential expression of four tumor microenvironment (TME)-related gene sets between tumor and control groups. Subsequently, unsupervised clustering analysis of tumor tissues identified two significantly distinct clusters. We calculated the differential scores of the four TME-related gene sets for Clusters 1 (C1) and 2 (C2), using Gene Set Variation Analysis (GSVA, followed by single-variable Cox analysis. For the two clusters, we performed survival analysis, examined disparities in clinical-pathological distribution, analyzed immune cell infiltration and immune evasion prediction, assessed differences in immune infiltration abundance, and evaluated drug sensitivity. Differentially expressed genes (DEGs) between the two clusters were subjected to Gene Ontology (GO) and Gene Set Enrichment Analysis (GSEA). We conducted Weighted Gene Co-expression Network Analysis (WGCNA) on the TARGET-OS dataset to identify key genes, followed by GO enrichment analysis. Using LASSO and multiple regression analysis we conducted a prognostic model comprising eleven genes (ALOX5AP, CD37, BIN2, C3AR1, HCLS1, ACSL5, CD209, FCGR2A, CORO1A, CD74, CD163) demonstrating favorable diagnostic efficacy and prognostic potential in both training and validation cohorts. Using the model, we conducted further immune, drug sensitivity and enrichment analysis. We performed dimensionality reduction and annotation of cell subpopulations in single cell sequencing analysis, with expression profiles of relevant genes in each subpopulation analyzed. We further substantiated the role of ACSL5 in OS through a variety of wet lab experiments. Our study provides new insights and theoretical foundations for the prognosis, treatment, and drug development for OS patients.
Supplemental Data from Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases

Di Wang,Xiaohui Niu,Zhijie Wang,Cheng-Li Song,Zhen Huang,Ke-Neng Chen,Jianchun Duan,Hua Bai,Jiachen Xu,Jun Zhao,Yu Wang,Minglei Zhuo,X. Sunney Xie,Xiaozheng Kang,Yanhua Tian,Liangliang Cai,Jie-Fei Han,Tongtong An,Yu Sun,Shugeng Gao,Jianming Ying,Luhua Wang,Jie He,Jie Wang

DOI: https://doi.org/10.1158/0008-5472.22421439

2023-01-01

Abstract:<p>Supplementary Figure S1-S16: Figure S1: landscape of variants in all samples; Figure S2: cancer cell fraction of each mutation; Figure S3: patient screen; Figure S4: high frequency CNV in each sample; Figure S5: SNV disparity between PT and MT; Figure S6: SV features; Figure S7: gene enrichment of each gene category; Figure S8: Jaccard similarity in each patient; Figure S9: clonal status of potential driver genes; Figure S10: mutation signature enrichment in trunk, PTun and MTun; Figure S11: mutation signature enrichment in PT and MT; Figure S12: mutation spectrum in PT and MT; Figure S13: immunohistochemistry of PD-L1 and CD8 in PT and MT; Figure S14: CNV of immune regulatory genes in all samples; Figure S15: response to immune checkpoint inhibitor in patient OS06. Figure S16: The genomic microsatellite stability state in all tumor samples.</p>

Additional File 5 of Abnormal Signal Pathways and Tumor Heterogeneity in Osteosarcoma

Supplementary Table 1 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Additional File 3 of Bioinformatics Integrated Analysis to Investigate Candidate Biomarkers and Associated Metabolites in Osteosarcoma

Table S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Table S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Additional File 7 of Transcriptomics and Metabolomics Reveal Changes in the Regulatory Mechanisms of Osteosarcoma under Different Culture Methods in Vitro

Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Additional File 8 of the Immune Subtypes and Landscape of Sarcomas

Figure S5 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Additional File 2: Figure S1. of Aberrant KDM5B Expression Promotes Aggressive Breast Cancer Through MALAT1 Overexpression and Downregulation of Hsa-Mir-448

Figure S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Additional File 2 of A Tumor Microenvironment-Based Prognostic Index for Osteosarcoma

Supplementary Table S16 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Additional File 19 of Single-cell RNA-seq Reveals the Genesis and Heterogeneity of Tumor Microenvironment in Pancreatic Undifferentiated Carcinoma with Osteoclast-Like Giant-Cells

Exploring the heterogeneity of osteosarcoma cell characteristics and metabolic states and their association with clinical prognosis

Supplementary Data from Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases

Additional File 14 of A Single-Cell Survey of Cellular Hierarchy in Acute Myeloid Leukemia

Abstract 1418: Screening and Identification of Key Surface Markers of Mesenchymal Stem Cell Osteogenic Differentiation and Osteosarcoma Development

Comprehensive investigation of tumor immune microenvironment and prognostic biomarkers in osteosarcoma through integrated bulk and single-cell transcriptomic analysis

Supplemental Data from Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases